These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 24128102

  • 1. [Assessment of the utilization of angiotensin receptor blockers in hypertension].
    Peña Cabia S, Ricote Lobera I, Santos Mena B, Hidalgo Correas FJ, Climent Florez B, García Díaz B.
    Farm Hosp; 2013; 37(5):394-8. PubMed ID: 24128102
    [Abstract] [Full Text] [Related]

  • 2. Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.
    Jain AK, Cuerden MS, McLeod I, Hemmelgarn B, Akbari A, Tonelli M, Quinn RR, Oliver MJ, Garg AX.
    Kidney Int; 2012 Jun; 81(12):1248-53. PubMed ID: 22437415
    [Abstract] [Full Text] [Related]

  • 3. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
    Márquez PHP, Torres OH, San-José A, Vidal X, Agustí A, Formiga F, López-Soto A, Ramírez-Duque N, Fernández-Moyano A, Garcia-Moreno J, Arroyo JA, Ruiz D, Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ Project.
    Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
    [Abstract] [Full Text] [Related]

  • 4. Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad.
    Tomas A, Tomić Z, Milijasević B, Ban M, Horvat O, Vukmirović S, Sabo A.
    Vojnosanit Pregl; 2016 Jun; 73(6):531-7. PubMed ID: 27498444
    [Abstract] [Full Text] [Related]

  • 5. Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors.
    Mahmoudpour SH, Asselbergs FW, de Keyser CE, Souverein PC, Hofman A, Stricker BH, de Boer A, Maitland-van der Zee AH.
    Int J Clin Pharm; 2015 Dec; 37(6):1095-103. PubMed ID: 26159317
    [Abstract] [Full Text] [Related]

  • 6. Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study.
    Mahmoudpour SH, Asselbergs FW, Souverein PC, de Boer A, Maitland-van der Zee AH.
    Br J Clin Pharmacol; 2018 Oct; 84(10):2365-2372. PubMed ID: 29943849
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluating prescription of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in patients with diabetes and albuminuria.
    Chienwichai K, Chaloemwa P, Sangkaew S, Chang A.
    Clin Nephrol; 2024 Jun; 101(6):277-286. PubMed ID: 38606848
    [Abstract] [Full Text] [Related]

  • 9. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S, Reichman ME, Houstoun M, Ross Southworth M, Ding X, Hernandez AF, Levenson M, Li L, McCloskey C, Shoaibi A, Wu E, Zornberg G, Hennessy S.
    Arch Intern Med; 2012 Nov 12; 172(20):1582-9. PubMed ID: 23147456
    [Abstract] [Full Text] [Related]

  • 10. Angioedemas associated with renin-angiotensin system blocking drugs: Comparative analysis of spontaneous adverse drug reaction reports.
    Dubrall D, Schmid M, Stingl JC, Sachs B.
    PLoS One; 2020 Nov 12; 15(3):e0230632. PubMed ID: 32214375
    [Abstract] [Full Text] [Related]

  • 11. The impact of the 'Better Care Better Value' prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental design.
    Baker A, Chen LC, Elliott RA, Godman B.
    BMC Health Serv Res; 2015 Sep 10; 15():367. PubMed ID: 26359265
    [Abstract] [Full Text] [Related]

  • 12. General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.
    Hirt MN, Muttardi A, Helms TM, van den Bussche H, Eschenhagen T.
    Clin Res Cardiol; 2016 May 10; 105(5):441-50. PubMed ID: 26552905
    [Abstract] [Full Text] [Related]

  • 13. How Admission to a Vascular Surgery Department Improves Medical Treatment in Patients with Lower Extremity Peripheral Arterial Disease.
    Thiney M, Della Schiava N, Feugier P, Lermusiaux P, Ninet J, Millon A, Long A.
    Ann Vasc Surg; 2017 Apr 10; 40():85-93. PubMed ID: 27908822
    [Abstract] [Full Text] [Related]

  • 14. Use of guideline-recommended therapies for heart failure in the Medicare population.
    DiMartino LD, Shea AM, Hernandez AF, Curtis LH.
    Clin Cardiol; 2010 Jul 10; 33(7):400-5. PubMed ID: 20641116
    [Abstract] [Full Text] [Related]

  • 15. Angioedema related to Angiotensin inhibitors.
    Knecht SE, Dunn SP, Macaulay TE.
    J Pharm Pract; 2014 Oct 10; 27(5):461-5. PubMed ID: 25124378
    [Abstract] [Full Text] [Related]

  • 16. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
    Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J.
    Am J Kidney Dis; 2005 Dec 10; 46(6):1080-7. PubMed ID: 16310574
    [Abstract] [Full Text] [Related]

  • 17. Use of ACE inhibitors and ARBs in hypertensive women of childbearing age.
    Martin U, Foreman MA, Travis JC, Casson D, Coleman JJ.
    J Clin Pharm Ther; 2008 Oct 10; 33(5):507-11. PubMed ID: 18834365
    [Abstract] [Full Text] [Related]

  • 18. Provider factors influencing prescriptions of recommended antihypertensive medications among patients with diabetes and hypertension
.
    Kang HJ, Song I, Kim YY, Park JH, Ha S, Jang S.
    Int J Clin Pharmacol Ther; 2019 Aug 10; 57(8):393-401. PubMed ID: 31131826
    [Abstract] [Full Text] [Related]

  • 19. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
    Bramlage P, Schmieder RE, Gitt AK, Baumgart P, Mahfoud F, Buhck H, Ouarrak T, Ehmen M, Potthoff SA, EARLY Registry Group.
    Trials; 2015 Dec 19; 16():581. PubMed ID: 26686682
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR, Romero B, Fernandez-Carbonero E, Sánchez-Casado E, Cubero JJ.
    J Renin Angiotensin Aldosterone Syst; 2009 Dec 19; 10(4):195-200. PubMed ID: 20026868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.